Marijuana Company Bud Genius in Talks to Acquire High Profile Celebrity Product Endorsements
10 October 2014 - 11:37PM
Business Wire
Bud Genius (Symbol: RIGH) is currently negotiating exclusive
product endorsement and licensing deals with celebrities, stars,
entertainers, and other household names. Competitors in the
industry have eagerly but unsuccessfully sought these high profile
endorsement agreements in the past, intending to brand
cannabis-related products using celebrity images. Now, however, Bud
Genius’ success in acquiring these celebrity partnerships may give
the company massive new gain potential. Bud Genius has the
opportunity to become the only publicly traded company in the
cannabis industry to profit from numerous agreements with smaller
businesses nationwide looking to become a part of something bigger,
and in the process gain access to resources previously available
only to much larger corporations. Simply put, for Bud Genius, this
could be like dropping a whale in a bathtub.
These exclusive celebrity endorsement contracts are being
negotiated by Bud Genius’ new subsidiary, Genius Biotech
Corporation, a Delaware corporation preparing for its audit and S-1
registration for listing on the OTC:BB. CEO Angel Stanz said, “From
McDonalds to Rolls-Royce, the power of branding has been proven
over and over again. We are bringing this power of branding to the
cannabis industry. The magnitude of these contracts dwarfs Bud
Genius, and soon everyone will be able to see why we needed to
create the new OTC:BB subsidiary. It is hard to describe how
incredibly excited I am for our team in putting this together, and
I am pleased to give this news to our shareholders today. As
cannabis and marijuana-related products continue to rise in
popularity throughout the United States, celebrities are looking to
get on board with the movement and ride the cannabis legalization
train. Early and isolated trials for celebrity-branded products
have resulted in sellout events. After the initial launch is
complete, Bud Genius expects to introduce this model to other
medical, adult-use recreational, and cannabis-friendly states.”
In pursuing these deals, we have found that celebrities often
prefer to endorse very specific genetic profiles, medicinal
effects, and quality markers. Bud Genius testing makes it uniquely
possible for high profile individuals to put their personal stamp
of approval on their preferred products. Only products identified
as being of the highest quality through Bud Genius laboratory
testing will qualify for use in one of the numerous celebrity
brands currently in development, and every branded product will be
matched using Bud Genius’ exacting quality standards. Interested
dispensaries and other distributors must qualify to carry each
brand individually, meeting all necessary legal requirements in
their state and local region.
Bud Genius will also add non-THC products to its sales
distribution channel, including celebrity branded hemp products,
hemp infused edibles, and consumption devices. The company recently
completed a stock repurchase, lowering its outstanding and
authorized shares by about 5%. For more information about Bud
Genius products, please visit the company website,
www.budgenius.com.
About Bud GeniusAn early leader in an industry that many
are speculating will grow, Bud Genius is one of the first
established analytical cannabis laboratories in the United States.
Bud Genius was launched to bring vendors together with doctors,
patients, and dispensaries that require certified products held to
demanding standards. Bud Genius has a vision to expand across the
US and abroad serving as the beacon of quality for medical cannabis
and adult-use marijuana through the formation of regional
laboratories. Certification, data collection, and online reports
are the measure by which the company gains.
For more information please visit:http://www.BudGenius.com
The foregoing press announcement contains forward-looking
statements that can be identified by such terminology such as
"believes," "expects," "potential," "plans," "suggests," "may,"
"should," "could," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results
to be materially different from any future results, performance or
achievements expressed or implied by such statements. In
particular, management's expectations could be affected by, among
other things, uncertainties relating to our success in completing
acquisitions, financing our operations, entering into strategic
partnerships, engaging management and other matters disclosed by us
in our public filings from time to time. Forward-looking statements
speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the
forward-looking statements are made.
Bud GeniusAngel Stanz, Chief Executive
Officer855-723-3283PR@BudGenius.com
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Apr 2024 to May 2024
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From May 2023 to May 2024